Market Trends of United Kingdom Ultrasound Devices Industry
This section covers the major market trends shaping the UK Ultrasound Devices Market according to our research experts:
High-intensity Focused Ultrasound Segment is Expected to Hold a Significant Market Share Over the Forecast Period
Focused ultrasonic energy is a non-invasive method for tissue ablation, it can be used to treat a variety of solid tumours. High-intensity focused ultrasound is being utilised more frequently to treat both primary and metastatic tumours because it can accurately identify tumours for ablation. Factors such as increasing cancer prevalence and initiatives by key players are expected to increase the market growth. The United Kingdom reported 457,960 new instances of cancer in 2020, according to the Globocan 2020 survey, with prostate, breast, colorectal, lung, and melanoma cancer being the most prevalent forms. The same source also predicts an increase in cancer cases, with predictions for 2030 and 2040 placing the total at 528,902 and 595,909, respectively.
The government's increasing funding initiatives for high-intensity focused ultrasound (HIFU) equipment are anticipated to fuel the industry's expansion in the UK. For instance, the National Health Service (NHS) England has authorized funding for MR-guided Focused Ultrasound for the treatment of patients with Essential Tremors who are unresponsive to medicine beginning in April 2021. As a research collaborator in the creation of this method, St. Mary's Hospital in London is the first facility in the United Kingdom to provide Focused Ultrasound to patients with medication-resistant Essential Tremor. This is expected to increase market growth. A review of high-intensity focused ultrasound (HIFU) in urology was published in November 2021 in the Multidisciplinary Digital Publishing Institute in the United Kingdom. According to this study, HIFU is one of many prostate cancer treatments currently available. It can be used as a salvage treatment after radiotherapy or as the main treatment that can be repeated. In some cases, prostate HIFU is accepted as a localized therapy in urological surgery and may have fewer side effects than other localized therapies. This will result in a rise in the usage of HIFU systems in the United Kingdom's healthcare system for the radiation treatment of prostate cancer and other conditions, which is anticipated to fuel the expansion of high-intensity focused ultrasound systems there.
Hence, the above developments pertaining to high-intensity focused ultrasound systems, it is expected to drive market growth in the country.
